Download Alphabet App Get Offers 5
Download Alphabet AppGet Offers
5 • Download App for exclusive offers
IngredientsCheck your order
Việt Nam
English
CÔNG TY TNHH THƯƠNG MẠI DỊCH VỤ ALPHABET
0
Your shopping cart is empty!
Fenofibrat 200mg DMC (3 blisters x 10 capsules/box)
Brand: DomescoProduct Code: A673767628

Fenofibrat 200mg DMC (3 blisters x 10 capsules/box)

29 reviewsWrite a review Kiểm duyệt chuyên môn

Fenofibrate, a fibric acid derivative, is a hypolipidemic drug. By inhibiting the hepatic biosynthesis of cholesterol, fenofibrate reduces atherogenic fractions and raises the production of HDL and reduces blood triglycerides. Thus, The repartition of plasma cholesterol is markedly ameliorated.

This product requires pharmacist consultation
Complying with medical pharmaceutical distribution regulations
This product requires advice from a professional pharmacist before use. Self-service online ordering is not supported.
100% Genuine MedicineGPP Ministry of Health standard
24/7 Pharmacist ConsultationHigh expertise, dedicated, correct dose
Express DeliveryFast, proper medicine storage
Convenient ReturnsProtecting patient rights
Share: Facebook Zalo

Indications

  • Treatment of severe hypertriglyceridaemia with or without low HDL cholesterol.
  • Mixed hyperlipidaemia when a statin is contraindicated or not tolerated or in patients at high cardiovascular risk in addition to a statin when triglycerides and HDL cholesterol are not adequately controlled.

Contraindications

  • Known hypersensitivity to any of the ingredients.
  • Severe renal dysfunction.
  • Hepatic insufficiency (including biliary cirrhosis and unexplained persistent liver function abnormality).
  • Chronic or acute pancreatitis with the exception of acute pancreatitis due to severe hypertriglyceridemia.
  • Known photoallergy or phototoxic reaction during treatment with fibrates or ketoprofen.
  • Known gallbladder disease.

Compositon/Ingredients

Fenofibrate 200mg

Dosage and administration

  • Adults, geriatric populations: 1 tablet/day.
  • Renal impairment: Dosage reduction is required.
  • Severe chronic kidney disease, hepatic impairment, children < 18 years: Fenofibrate is not recommended for use.

Precaution

  • In patients taking anticoagulants, the dose of anticoagulant should be reduced by about one third when treatment with fenofibrate is started. Check the prothrombin level more frequently and adapt the dosage of oral anticoagulant during treatment by fenofibrate and 8 days after its interruption.
  • Hypothyroidism may be a factor predisposing to the muscle syndrome.
  • Measurement of transaminases every 3 months, during the first 12 months of treatment, temporary interruption of treatment in case of an increase in SGPT (ALT) to > 100 IU.
  • Biliary complications are more prone to occur in patients with biliary cirrhosis or gallstones.
  • Fenofibrate therapy should be discontinued if serum CPK concentrations become markedly elevated or if myositis/myopathy is suspected or diagnosed.
  • Stevens-Johnson syndrome and toxic epidermal necrolysis, pancreatitis.
  • Pregnancy and lactation.
  • Patients should be aware of how they react to drug before driving or operating machinery.

Storage

Store at temperature below 30°C, protect from light.

Ask a question about this product



Write a review

Share your real experience using this product

Log in to write a review

Only customers who have purchased this product at Alphabet Pharma can submit a verified review.

Log in now
Fenofibrat 200mg DMC (3 blisters x 10 capsules/box)

Fenofibrat 200mg DMC (3 blisters x 10 capsules/box)

Contact Pharmacist